AWS is delighted to be working alongside a rapidly growing healthcare medical technology company in the development and manufacture of an innovative state-of-the-art medical device.
The diabetes monitoring product, first launched in 2016, has received extensive recognition for its unique ability to monitor both blood glucose and blood ketones in diabetic patients, with the ability to provide warnings when levels exceed limits that are clinically relevant.
AWS has supported this highly-invested UK start-up with a clear manufacturing strategy to aid their cutting-edge biometric technology, recognising ‘speed to market’ as a critical factor in the success of a new product launch. AWS’ vast experience within the medical devices industry, coupled with its ISO 13485 and ISO 9001:2015 accreditations, make AWS the right partner in the complex PCBA and unit assembly required for the ground-breaking device.
Paul Deehan, CEO, comments: “We are delighted once again to be working with a revolutionary start-up in the medical sector, supporting a company with fantastic IPR, who are using modern technology in and around real-time monitoring of blood glucose and ketones in patients.”
AWS provide services for the entire electronic product life-cycle and are therefore fully equipped to support this fast-growing organisation as they move from NPI requirements to higher-volume manufacturing needs. AWS also provide the opportunity, where required, to move production to its low-cost manufacturing facility in Námestovo, Slovakia.
Learn more about AWS at www.awselectronicsgroup.com.